nephrocare health services limited IPO
About Company
As of Sep 30, 2025, Nephrocare operated 519 clinics with 51 across the Philippines, Uzbekistan, and Nepal. This includes the world’s largest dialysis clinic in Uzbekistan. In India, the company had a presence across 288 cities in 21 States and 4 Union Territories. Approximately 77.53% of its clinics were located in tier II and tier III cities, addressing a critical need in underserved regions.
During Fiscal 2025, Nephrocare served 29,281 patients and completed 2,885,450 dialysis treatments, accounting for roughly 10% of the country's total dialysis patient base. Additionally, by Sep 30, it has served 31,046 patients and completed 1,591,377 treatments in India. As of Sep 30, 2025, the company has 5,562 dialysis machines.
Nephrocare has formed strategic partnerships with established hospital chains such as Max Super Speciality Hospital, Fortis Escorts Hospitals, Care Hospitals, Wockhardt Hospitals, Paras Healthcare, The Calcutta Medical Research Institute, Jehangir Hospital, and Ruby Hall Clinic to operate in-house dialysis centers.
Competitive strengths
India’s and Asia’s largest dialysis chain with leadership across our markets
Scale coupled with asset-light model driving cost efficiencies and operational excellence
Driving clinical excellence and quality through protocols and advanced technology
Organic growth augmented by proven track record of acquisitions and integration in India and internationally
Patient-centric leadership and seasoned management team backed by marquee investors
Driving sustainable dialysis leadership with environmental, social and governance measures
Track record of sustainable growth, profitability and return
Investment Objective
Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by the Company
General corporate purposes
Important Dates
Financial Performance
IPO Lot Size
Issue Details
5 th Floor, D Block, iLabs Centre,
Plot 18, Software Units Layout,
Survey No. 64, Madhapur, Shaikpet,
Hyderabad, Telangana, 500081
Registrar
Financial District, Nanakramguda, Gachibowli,
Hyderabad, Telangana India - 500 032.
Nephrocare health services limited IPO is a public issue in which the company offers its equity shares to investors through the stock exchange. The IPO allows retail investors, HNIs, and institutional investors to participate.
The IPO price band of Nephrocare health services limited IPO is ₹438 to ₹460 per share, as mentioned in the issue details.
The minimum investment in Nephrocare health services limited IPO is ₹14720, based on the minimum lot size applicable for retail investors.
The lot size of Nephrocare health services limited IPO is 32 shares per lot, and applications must be made in multiples of this lot size.
Nephrocare health services limited IPO opens on 10 Dec 2025 and closes on 12 Dec 2025, as per the announced IPO schedule.
The Nephrocare health services limited IPO subscription status shows how many times the issue has been subscribed across retail, HNI, and institutional categories during the IPO period.
The Nephrocare health services limited IPO GMP (Grey Market Premium) today is around ₹undefined, reflecting current grey market activity before listing.
Nephrocare health services limited IPO GMP is currently negative, indicating prevailing sentiment in the grey market. GMP may change daily based on demand.
A positive Nephrocare health services limited IPO GMP may suggest potential listing interest, while actual listing performance depends on subscription levels and overall market conditions.
From a retail investor perspective, Nephrocare health services limited IPO is evaluated based on pricing, lot size, subscription trends, and market sentiment. Investors should assess these factors before applying.
The Nephrocare health services limited IPO listing date is expected to be 17 Dec 2025, subject to completion of allotment and exchange procedures.
The expected listing price of Nephrocare health services limited shares depends on demand, subscription response, GMP trends, and overall market sentiment at the time of listing.
Nephrocare health services limited IPO allotment status can be checked online once the allotment process is completed using PAN, application number, or DP ID details.
Nephrocare health services limited IPO is categorized as a Mainboard IPO based on the exchange and issue structure.
Yes, Nephrocare health services limited IPO subscription figures and GMP may change during the issue period and before listing due to market activity and investor demand.